Background illustration for clinical trials search

Paid Clinical Trials Jersey City

Discover 1,567 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

for
Metastatic Non Small Cell Lung Cancer
Location: New York NY, Camden NJ, Richmond VA, Natrona Heights PA,
Sponsor: Iovance Biotherapeutics, Inc.

Sex: All

Age: 18 - 70

Code: NCT04614103

Phase2, Recruiting

Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature

for
Peripheral Vascular Diseases
Location: New York NY, Newark NJ, Hackensack NJ, New Haven CT,
Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT04674969

Recruiting

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

for
Colitis, Ulcerative
Location: New York NY, Marlton NJ, Glen Burnie MD, Chevy Chase MD,
Sponsor: Pfizer

Sex: All

Age: 18 - 64

Code: NCT06398626

Recruiting

CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)

for
Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma,
Location: New York NY, Hackensack NJ, Bronx NY, Morristown NJ,
Sponsor: Caribou Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT04637763

Phase1, Recruiting

EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND)

for
Single Gene NIPT
Location: New York NY, New Hyde Park NY, Garden City NY,
Sponsor: Natera, Inc.

Sex: All

Age: 18+

Code: NCT06808880

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations.

for
Peripheral Nerve Injury Upper Limb,
Location: New York NY, Camden NJ, Philadelphia PA, Baltimore MD,
Sponsor: Neuraptive Therapeutics Inc.

Sex: All

Age: 18 - 70+

Code: NCT06616025

Phase3, Recruiting

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

for
Cardiovascular Diseases, Heart Diseases, Heart Failure
Location: New York NY, Newark NJ, The Bronx NY, Philadelphia PA,
Sponsor: BrioHealth Solutions, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06310031

Recruiting

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

for
Pancreatic Ductal Adenocarcinoma (PDAC), G12D Mutated KRAS
Location: New York NY, East Brunswick NJ, Baltimore MD, Boston MA,
Sponsor: Verastem, Inc.

Sex: All

Age: 18+

Code: NCT07644559

Phase2, Recruiting

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: New York NY, Mineola NY, East Brunswick NJ, Shirley NY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07518186

Phase3, Recruiting

IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

for
Relapsed/Refractory Primary Central Nervous System Lymphoma
Location: New York NY, Hackensack NJ, Summit NJ, New Haven CT,
Sponsor: Ono Pharmaceutical Co., Ltd.

Sex: All

Age: 18+

Code: NCT07104032

Phase3, Recruiting

A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older

for
Clostridoides Difficile Associated Disease
Location: New York NY, Brooklyn NY, Long Island City NY,
Sponsor: Pfizer

Sex: All

Age: 65+

Code: NCT07282665

Phase3, Recruiting

A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

for
Colorectal Cancer
Location: New York NY, New Brunswick NJ, New Haven CT,
Sponsor: Criterium, Inc.

Sex: All

Age: 18+

Code: NCT06992258

Phase2, Recruiting

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

for
Solid Tumor, Adult, Non-small Cell Lung Cancer, Melanoma
Location: New York NY, Morristown NJ, New Brunswick NJ,
Sponsor: Pierre Fabre Medicament

Sex: All

Age: 18+

Code: NCT04913285

Phase1, Recruiting

Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation

for
Basal Ganglia Intracerebral Hemorrhage
Location: New York NY, New Brunswick NJ, New Haven CT,
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18 - 70+

Code: NCT07260916

Recruiting

A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies

for
Hematologic Neoplasms
Location: New York NY, Piscataway NJ, Grand Rapids MI,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07572006

Phase1, Recruiting

Shield Post-Approval Study Protocol

for
Colo-rectal Cancer
Location: New York NY, Montclair NJ, Clifton NJ, Ridgewood NJ,
Sponsor: Guardant Health, Inc.

Sex: All

Age: 45 - 70+

Code: NCT06880055

Recruiting

A Study of Dotinurad Versus Allopurinol in Participants With Gout

for
Gout
Location: New York NY, Brooklyn NY, Oradell NJ, Sparta NJ,
Sponsor: Crystalys Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07089875

Phase3, Recruiting

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

for
Solid Cancer
Location: New York NY, Teaneck NJ, Paramus NJ, Lake Success NY,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06161025

Phase2, Phase3, Recruiting

A Study of Dotinurad Versus Allopurinol in Tophaceous Gout

for
Tophaceous Gout
Location: New York NY, Brooklyn NY, Oradell NJ,
Sponsor: Crystalys Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07089888

Phase3, Recruiting

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

for
Low-grade NMIBC, FGFR Gene Amplification, FGFR Gene Alterations,
Location: New York NY, Astoria NY, The Bronx NY, Morristown NJ,
Sponsor: Tyra Biosciences, Inc

Sex: All

Age: 18+

Code: NCT06995677

Phase2, Recruiting